Clinical trial · Interventional
The Effectiveness of the LCP in Improving End of Life Care for Dying Cancer Patients in Hospital.
The Effectiveness of the Liverpool Care Pathway in Improving End of Life Care for Dying Cancer Patients in Hospital. A Cluster Randomised Trial.
NCT01081899CI-TRIAL-00008894completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the effectiveness of the LCP-I Program in improving the quality of end-of-life care provided to cancer patients who die on hospital medical wards as compared to standard healthcare practices.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| The LCP-I Program | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- The LCP-I Program.
- description
- The Italian version of the Liverpool Care Pathways version 11 for hospital) Programme.
- interventionNames
- Other: The LCP-I Program
- type
- NO_INTERVENTION
- label
- standard healthcare practices
- description
- No specific interventions are planned in the control wards.
Primary outcomes (1)
- measure
- Quality of end-of-life care provided to dying cancer patients and their families.
- timeFrame
- six months after the implementation of the LCP Program
- description
- Measured through the Global Scale of the Italian version of the Toolkit "After-death Bereaved Family Member Interview" (Teno J, et al 2001).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Ward level Inclusion Criteria: * "Medical", "General Medical" or "Internal Medical" ward; * at least 25 cancer deaths on the ward per year; * consent from the Hospital and Ward Management to participate to the trial; * consent from an expert and skills-trained PCU to implement the LCP-I Program Exclusion Criteria: \- in the hospital another Medical Ward has already been randomised. Individual level Inclusion Criteria: \- all cancer patients deceased in the ward during the evaluation period; Exclusion Criteria: \- the deceased was a relative of a professional working in the hospital.
References
Publications (2)
- DERIVEDCostantini M, Romoli V, Leo SD, Beccaro M, Bono L, Pilastri P, Miccinesi G, Valenti D, Peruselli C, Bulli F, Franceschini C, Grubich S, Brunelli C, Martini C, Pellegrini F, Higginson IJ; Liverpool Care Pathway Italian Cluster Trial Study Group. Liverpool Care Pathway for patients with cancer in hospital: a cluster randomised trial. Lancet. 2014 Jan 18;383(9913):226-37. doi: 10.1016/S0140-6736(13)61725-0. Epub 2013 Oct 16. PMID 24139708
- DERIVEDCostantini M, Ottonelli S, Canavacci L, Pellegrini F, Beccaro M; LCP Randomised Italian Cluster Trial Study Group. The effectiveness of the Liverpool care pathway in improving end of life care for dying cancer patients in hospital. A cluster randomised trial. BMC Health Serv Res. 2011 Jan 24;11:13. doi: 10.1186/1472-6963-11-13. PMID 21261949